AMY MITCHELL: Open Payments
NPI 1407485345 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 21 payments from 10 companies in 2025. Trend: 2023 $228 · 2024 $252 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $145 |
| Lilly USA, LLC | 2 | $36 |
| Novo Nordisk Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Avvisto Therapeutics, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $8 |
Products named: UBRELVY, QULIPTA, MOUNJARO, Wegovy, The Cologuard Plus Collection Kit, PAXLOVID, Veozah, CYCLOSET.
Industry payments across TX — which companies pay providers there.
